Dimension Vista Thyroxine (T4) assay; (Product Number: K6065/10445101) (Mfr: Siemens Healthcare Diagnostics, Newark, DE)
Published May 16, 2018 · Recall initiated: June 29, 2017
Summary
FDA records medical device Class II recall Z-1660-2018, published May 16, 2018 and initiated June 29, 2017. Recalling firm: Siemens Healthcare Diagnostics, Inc.; Status: Terminated; Reported quantity: 19,991; Lot: All lots. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Various assays used to measure different chemical levels in blood, urine, or cerebrospinal fluid may interfere with the drugs sulfasalazine and/or sulfapyridine causing falsely elevated or falsely depressed results.
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Siemens Healthcare Diagnostics, Inc.
- Distributor
- Distributed in all 50 U.S. states, the District of Columbia, Guam, and Puerto Rico. Distributed in 108 foreign countries: Afghanistan Bolivia Albania®¿¿¿¿¿¿¿ Algeria®¿¿¿¿¿¿¿ Angola ARGENTINA Armenia AUSTRALIA Austria®¿¿¿¿¿¿¿ Azerbaijan Bahamas Bahrain®¿¿¿¿¿¿¿ Bangladesh®¿¿¿¿ Belarus®¿¿¿¿¿¿¿ Belgium®¿¿¿¿¿¿¿ Bosnia®Herzeg.¿ Brazil Bulgaria®¿¿¿¿¿¿ Cambodia Canada Canary islands Chile China Colombia Costa Rica Croatia®¿¿¿¿¿¿¿ Cyprus®¿¿¿¿¿¿¿¿ Czech®Republic® Denmark®¿¿¿¿¿¿¿ Ecuador Egypt®¿¿¿¿¿¿¿¿¿ El Salavador Estonia®¿¿¿¿¿¿¿ Finland®¿¿¿¿¿¿¿ France®¿¿¿¿¿¿¿¿ Georgia Germany®¿¿¿¿¿¿¿ Greece®¿¿¿¿¿¿¿¿ Guatemala Honduras Hong Kong Hungary®¿¿¿¿¿¿¿ Iceland India Indonesia Iraq Ireland®¿¿¿¿¿¿¿ Israel®¿¿¿¿¿¿¿¿ Italy®¿¿¿¿¿¿¿¿¿ japan Jordan Kazakhstan®¿¿¿¿ Korea Kuwait Latvia®¿¿¿¿¿¿¿¿ Lebanon Lithuania®¿¿¿¿¿ Luxembourg®¿¿¿¿ Macedonia Malaysia Mali Malta®¿¿¿¿¿¿¿¿¿ Mexico Morocco®¿¿¿¿¿¿¿ Myanmar Nepal Netherlands®¿¿¿ New Zealand Nicaragua Norway®¿¿¿¿¿¿¿¿ Oman Pakistan®¿¿¿¿¿¿ Paraguay Peru Philippines Poland®¿¿¿¿¿¿¿¿ Portugal®¿¿¿¿¿¿ Qatar®¿¿¿¿¿¿¿¿¿ Romania®¿¿¿¿¿¿¿ Russian®Fed.¿¿¿ Saudi Arabia Senegal Serbia®¿¿¿¿¿¿¿¿ Serbia®¿¿¿¿¿¿¿¿ Singapore Slovakia®¿¿¿¿¿¿ Slovenia®¿¿¿¿¿¿ South Africa South Africa South Korea Spain®¿¿¿¿¿¿¿¿¿ Sri Lanka Sweden®¿¿¿¿¿¿¿¿ Switzerland®¿¿¿ Taiwan®¿¿¿¿¿¿¿¿ Tajikistan Thailand Tunisia®¿¿¿¿¿¿¿ Turkey®¿¿¿¿¿¿¿¿ Turkmenistan®¿¿ United Arab Emerites®¿¿¿¿¿ United®Kingdom® Uruguay®¿¿¿¿¿¿¿ Uzbekistan Vatikancity®¿¿¿ Venezuela Vietnam Yemen
- Lot
- All lots
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAAtellica CH Revised C-Reactive Protein (RCRP); Siemens Material Number (SMN): 11537223;October 7, 2026
- FDABeckman Coulter, Emit 2000 Quinidine Assay REF: OSR4Q229 Contents: R1: 2 x 23 mL;R2 2x13 mLAugust 26, 2026
- FDASyva EMIT 2000 Quinidine Assay REF: 4Q019UL Contents: 1x28 mL, 1x14mLAugust 26, 2026
- FDASyva Emit tox Serum Tricyclic Antidepressant Calibrator/Controls SMN 10445390 Catalog No. 7C219ULAugust 12, 2026
- FDARESTORIS MCK TIBIAL BASEPLATE-RM/LL used in unicompartmental knee arthroplasty and knee replacements.May 16, 2018
- FDAIMMULITE ¿ 2000/IMMULITE ¿ 2000 XPi Anti HBcMay 16, 2018
Questions about this recall
Was Dimension Vista Thyroxine (T4) assay; (Product Number: K6065/10445101) (Mfr: Siemens Healthcare Diagnostics, Newark, DE) recalled?
Yes. FDA published recall Z-1660-2018 on May 16, 2018. Reported hazard: Various assays used to measure different chemical levels in blood, urine, or cerebrospinal fluid may interfere with the drugs sulfasalazine and/or sulfapyridine causing falsely elevated or falsely depressed results.
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail